James Pedraza
Nurse Practitioner · Chicago, ILNPI 1649731910
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 197 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. Electronic Waveform Lab, Inc. accounts for 68.4% of it on its own, with 12 other manufacturers making up the rest. Reporting peaked in 2023 at $744 and has fallen 71.7% since, to $210 in 2024.
Across 197 payments — averaging $9.11 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Electronic Waveform Lab, Inc.$1K
- Abbott$155
- AbbVie$112
- Pacira Pharmaceuticals Incorporated$84
- Pfizer$59
- Collegium Pharmaceutical, Inc.$36
- plus $122 from 7 others
What the payments were for
- Food & beverage$1,796100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Electronic Waveform Lab, Inc. | 174 | $1,228 |
| Abbott | 3 | $155 |
| AbbVie | 6 | $112 |
| Pacira Pharmaceuticals Incorporated | 2 | $84 |
| Pfizer | 3 | $59 |
| Collegium Pharmaceutical, Inc. | 2 | $36 |
| Vertos Medical, Inc. | 1 | $25 |
| Biohaven Pharmaceuticals, Inc. | 1 | $21 |
| Redhill Biopharma Inc. | 1 | $19 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $17 |
| Kowa Pharmaceuticals America, Inc. | 1 | $16 |
| Merck | 1 | $13 |
| Biodelivery Sciences International, Inc. | 1 | $12 |
How this compares
$1,796 in reported general payments places this provider in the 85th percentile of 4,869 nurse practitioner providers in Illinois.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 88 | $4,103 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 13 | $720 |
| Gabapentin | 35 | $537 |
| Ibuprofen | 44 | $444 |
| Cyclobenzaprine Hcl | 31 | $329 |
| Tizanidine Hcl | 28 | $312 |
| Tramadol Hcl | 18 | $169 |
| Meloxicam | 19 | $100 |
Paid to pharmacies, not to this prescriber.
Other nurse practitioner in Chicago
- Erika VuckoChicago$76K
- Michelle MunroeChicago$64K
- Melanie SamardzijaChicago$42K
- Rana KennellyChicago$42K
- Fiona LynnChicago$41K
- Melissa DuckettChicago$30K
- Allison MorinChicago$27K
- Christy DavisChicago$19K
- Ariel HughChicago$17K
- Kelly DuganChicago$15K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.